Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.
about
Pulmonary Hypertension and Indicators of Right Ventricular FunctionPulmonary vasculature in COPD: The silent componentPulmonary capillary hemangiomatosis: a focus on the EIF2AK4 mutation in onset and pathogenesisMolecular mechanisms of pulmonary arterial remodelingDrug treatment of pulmonary hypertension in childrenApelin-APJ signaling: a potential therapeutic target for pulmonary arterial hypertensionExercise and NO production: relevance and implications in the cardiopulmonary systemExtending the translational potential of targeting NO/cGMP-regulated pathways in the CVSPulmonary arterial hypertension: a comparison between children and adultsTreatment-related biomarkers in pulmonary hypertensionAerosolised iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatmentResidual pulmonary vasoreactivity to inhaled nitric oxide in patients with severe obstructive pulmonary hypertension and Eisenmenger syndromeFunctional properties of a naturally occurring isoform of soluble guanylyl cyclaseChronic exposure to arsenic in tap water reduces acetylcholine-induced relaxation in the aorta and increases oxidative stress in female ratsRoles of accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, and attenuated nitric oxide synthase activity in endothelial cells for pulmonary hypertension in ratsImmunocytochemical mapping of the amidating enzyme PAM in the developing and adult mouse lungInhibition of compensatory lung growth in endothelial nitric oxide synthase-deficient mice.Inhaled iloprost in pulmonary arterial hypertension.Breath tests in respiratory and critical care medicine: from research to practice in current perspectivesRecent trends in pulmonary arterial hypertensionDependence of Golgi apparatus integrity on nitric oxide in vascular cells: implications in pulmonary arterial hypertension.Pulmonary arterial hypertension: the clinical syndrome.Nitric oxide donors regulate nitric oxide synthase in bovine pulmonary artery endothelium.Nitric oxide: a review for veterinary surgeons.Medical management of primary pulmonary hypertension.Pulmonary hypertension: diagnosis and managementThe noncanonical WNT pathway is operative in idiopathic pulmonary arterial hypertension.Early abnormalities of pulmonary vascular development in the Fawn-Hooded rat raised at Denver's altitude.Sex differences in the pulmonary circulation: implications for pulmonary hypertensionHypoxic repression of endothelial nitric-oxide synthase transcription is coupled with eviction of promoter histonesEndothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension.Emerging Metabolic Therapies in Pulmonary Arterial Hypertension.Hypoxia-induced pulmonary hypertension in type 2 diabetic mice.Development of pulmonary arterial hypertension in women: interplay of sex hormones and pulmonary vascular disease.Identifying "super responders" in pulmonary arterial hypertension.Endothelial Krüppel-like factor 4 modulates pulmonary arterial hypertensionTherapy for pulmonary arterial hypertension associated with systemic sclerosis.Effect of preoperative oral sildenafil on severe pulmonary artery hypertension in patients undergoing mitral valve replacementPulmonary arterial hypertension in adults: novel drugs and catheter ablation techniques show promise? Systematic review on pharmacotherapy and interventional strategies.The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia.
P2860
Q26744781-3A7F30C7-972D-41AE-8567-DBCD42AABC43Q26749309-17D47609-0F28-46D7-B8ED-E86FADBF2215Q26795562-4DD20C4D-24A0-4C4F-8504-24F36F195537Q26991806-C56CCB08-AFF0-4E2A-9571-FA48F6905B10Q26996078-7C26CDDA-5C06-4D33-BDB4-5277C19A232DQ27010531-248EA944-27CE-4DC5-81B1-048791FE349BQ27012707-A63FC22F-0231-49D6-A084-B8000BA8C31DQ27021649-37CBF049-9FA2-4720-AA0F-34309E093F9CQ27687320-42245DDA-1EF5-4B1B-AF08-7369996F5FA6Q28081276-3114758B-EAB4-4505-B8BE-CE30A7A85616Q28346517-91A360E0-02E7-4BA8-85BB-87D9103E7E4DQ28361795-3017C336-F77C-410B-B4DF-33596DFC8E4BQ28368954-D8DE7494-FE59-4D8A-8512-9084FF5B9F6AQ28572685-C6BC696F-70E2-4882-BE8E-8506280CA06EQ28578942-B4CF294E-3FFB-4116-A8E9-F0E6B06A0497Q28589299-DEA0FE61-972D-4E30-A1D2-CCE6561308C0Q30309331-72FFEA4B-2A29-4A8E-8FFD-074F9B971A0DQ30437211-22533721-2330-4ECA-8C6F-C2E5DDACFDBFQ30448113-A0A2C252-8EC2-46E8-BDC1-1278344FDC20Q30475192-F88060B0-8EEC-45AA-99B0-02FB08D610D3Q30499465-5C6529F8-14FE-4AE4-B4CA-457BBBB03DD0Q30583630-A2CE5AE5-7180-4CED-8193-80D06846A230Q31809877-1C22E9D7-7E17-46F6-91E6-32A6529DF77AQ31921905-ACF802F8-7597-48CA-86DC-3B45DF7813A6Q33147339-AA29101A-1110-40CD-A102-136FB416ABB1Q33157071-0DFCB1F5-77AD-4697-8D79-A5F038A00313Q33386662-3785127D-8E15-474C-986F-21ABDB093ECFQ33422125-C3ECBCB3-ACFF-44CF-8366-65D5012E2712Q33568826-BFE88D17-69A9-4688-B185-F7942FC4275BQ33569829-938787CB-F8D9-4F53-8E88-85F57EAEFF43Q33594460-A49ABAE5-3943-4729-A555-2D6E962EE4B7Q33608219-5103CC01-E3EE-4C1B-A30C-D02122E806ADQ33738536-053FF177-2AB0-4005-B58F-AFCE1ED28C90Q33786374-7CD0D202-6BBF-41B6-B97A-45E4B87F4B20Q33788452-5F034CA2-2564-4A50-885D-FC352A92D14AQ33799629-B1E12BC6-1851-4983-997D-2CC84B8FDC73Q33805746-C1C94ADC-1F10-4B16-9EF2-C884A6AF7A60Q33809395-358BDD80-2917-41BD-9760-35664AB5FDB5Q33810499-68E7CFA1-880E-4A2D-90D5-A06EC6A6B3B7Q33834815-B08E14A8-21A6-4998-84AA-FF2B0C322A7F
P2860
Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Reduced expression of endothel ...... s with pulmonary hypertension.
@ast
Reduced expression of endothel ...... s with pulmonary hypertension.
@en
Reduced expression of endothel ...... s with pulmonary hypertension.
@nl
type
label
Reduced expression of endothel ...... s with pulmonary hypertension.
@ast
Reduced expression of endothel ...... s with pulmonary hypertension.
@en
Reduced expression of endothel ...... s with pulmonary hypertension.
@nl
prefLabel
Reduced expression of endothel ...... s with pulmonary hypertension.
@ast
Reduced expression of endothel ...... s with pulmonary hypertension.
@en
Reduced expression of endothel ...... s with pulmonary hypertension.
@nl
P1476
Reduced expression of endothel ...... s with pulmonary hypertension.
@en
P304
P356
10.1056/NEJM199507273330403
P407
P577
1995-07-01T00:00:00Z